Egros Fabrice's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Nov 19, 2021
- Accession no.
- 0001562180-21-007180
- Filed
- Nov 19, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $253.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Egros FabriceCIK 0001597085 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Common Stock | MOption exerciseAcquired | +14,000 | $8.93 | +$125,020 | 30,000 | Direct | |
| Nov 18, 2021 | Common Stock | SSaleDisposed | −14,000 | $18.03F2 | −$252,420 | 16,000 | Direct | |
| Nov 18, 2021 | Common Stock | MOption exerciseAcquired | +30 | $7.88 | +$236.4 | 16,030 | Direct | |
| Nov 18, 2021 | Common Stock | SSaleDisposed | −30 | $18.03F2 | −$540.9 | 16,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Common Stock | MOption exerciseDisposed | 0 | $0.00 | $0 | 0 | Direct | |
| Nov 18, 2021 | Common Stock | MOption exerciseDisposed | 0 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale prices ranged from $18.03 to $19.03.
Referenced by the price of 2 transactions in Table I.